5:31 PM
 | 
May 18, 2007
 |  BC Extra  |  Company News

Johnson & Johnson submits ceftobiprole NDA

JNJ submitted an NDA to FDA for ceftobiprole to treat complicated skin and skin structure infections (cSSSIs)....

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >